福瑞达业绩说明会：颐莲喷雾高增瑷尔蓄势 品牌与科技双轮驱动发展

Core Viewpoint - The company, Furuida, reported a strong performance in Q1 2025, with significant growth in its core brand Yilian and a focus on brand enhancement and technological innovation amidst a volatile external environment [1][2]. Group 1: Financial Performance - In Q1 2025, the company achieved a revenue of 876 million yuan and a net profit of 50.71 million yuan, aligning with market expectations [2]. - The cosmetics segment generated a revenue of 526 million yuan with a gross margin of 61.1%, indicating strong profitability [2][3]. Group 2: Brand and Product Development - The Yilian brand recorded a revenue of 250 million yuan, a 25% year-on-year increase, with spray product sales surging by 69% [2]. - The company plans to focus on its two main brands, Yilian and Aier Doctor, and enhance product lines in sprays, probiotics, and collagen to drive growth [2]. Group 3: Research and Development - The company invested approximately 42 million yuan in R&D in Q1 2025, focusing on new product development and technological breakthroughs across cosmetics, pharmaceuticals, and raw materials [3]. - The company has achieved 12 new patent authorizations and launched 47 new products in the first quarter [3]. Group 4: Pharmaceutical and Raw Material Business - The pharmaceutical segment generated a revenue of 108 million yuan, remaining stable year-on-year, with a gross margin of 54.8% [3]. - The raw materials and additives segment achieved a revenue of 86 million yuan, a 2.4% increase year-on-year, with a gross margin rising nearly 10 percentage points to 39.54% [3].